Breast Cancer

Breast cancer screening guidelines: discrepancies raise concerns about validity

Nikita Jhangiani, Megha Philip, Ismail Jatoi

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition

Mitsuo Terada, Aki Ito, Yuichiro Kikawa, Kei Koizumi, Yoichi Naito, Tatsunori Shimoi, Mikiya Ishihara, Takashi Yamanaka, Yukinori Ozaki, Fumikata Hara, Rikiya Nakamura, Masaya Hattori, Minoru Miyashita, Naoto Kondo, Tetsuhiro Yoshinami, Masahiro Takada, Koji Matsumoto, Kazukata Narui, Shinsuke Sasada, Takayuki Iwamoto, Mitsuchika Hosoda, Yuko Takano, Takaaki Oba, Hitomi Sakai, Akari Murakami, Toru Higuchi, Junko Tsuchida, Yuko Tanabe, Tomoko Shigechi, Emi Tokuda, Michiko Harao, Shinichiro Kashiwagi, Junichi Mase, Junichiro Watanabe, Shigenori E. Nagai, Chikako Yamauchi, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji, Tatsuya Toyama

Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review

Orellana-Jaén Jesús, Carrasco-Páez Luis, Mora-Fernández Matilde

MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis

R. L. Akshaya, I. Saranya, N. Selvamurugan

Self-help management of patients undergoing chemotherapy: analysis of the online forum of the women’s self-help association against cancer

C. Colditz, C. Keinki, J. Huebner

Significance of skeletal muscle index-to-body mass index ratio as a predictor of post-surgical bleeding after mastectomy in patients with breast cancer

Hiroki Morikawa, Takaaki Oba, Nami Kiyosawa, Ryoko Iji, Masatsugu Amitani, Tatsunori Chino, Tadafumi Shimizu, Mayu Ono, Tokiko Ito, Toshiharu Kanai, Kazuma Maeno, Ken-ichi Ito

Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316)

Manabu Futamura, Takahiro Nakayama, Tetsuhiro Yoshinami, Chiya Oshiro, Mikiya Ishihara, Midori Morita, Akira Watanabe, Azusa Tanigichi, Masami Tsukabe, Masafumi Shimoda, Kanae Nitta, Yoko Chihara, Hiroyuki Yasojima, Yoshimi Ouchi, Yoshihisa Tokumaru, Norikazu Masuda

Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan

Chitose Kawamura, Masao Iwagami, Yu Sun, Jun Komiyama, Tomoko Ito, Takehiro Sugiyama, Hiroko Bando, Nanako Tamiya

Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis

Chengxin Li, Qianqian Yuan, Tong Deng, Gaoran Xu, Jinxuan Hou, Lewei Zheng, Gaosong Wu

Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: variations in intrinsic subtypes, and strategy to improve negative predictive value—an analysis of 2473 invasive breast cancer patients

Shu-Tian Chen, Hung-Wen Lai, Julia Huei-Mei Chang, Chiung-Ying Liao, Tzu-Cheng Wen, Wen-Pei Wu, Hwa-Koon Wu, Ying-Jen Lin, Yu-Jun Chang, Shou-Tung Chen, Dar-Ren Chen, Hsin-I Huang, Che-Lun Hung

Prognosis of post-neoadjuvant therapy patients who underwent immediate breast reconstruction: a SEER-based, propensity-matched study

Jiahao Pan, Liying Peng, Xiuwen Tong, Xipei Chen, Xinyun Xu, Jian Zhang

Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy

Silvia Mihaela Ilie, Nathalie Briot, Guillaume Constantin, Nicolas Roussot, Alis Ilie, Anthony Bergeron, Laurent Arnould, Françoise Beltjens, Isabelle Desmoulin, Didier Mayeur, Courèche Kaderbhai, Audrey Hennequin, Clémentine Jankowski, Marie Martine Padeano, Helène Costaz, Alix Amet, Charles Coutant, Bruno Coudert, Aurélie Bertaut, Sylvain Ladoire

Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data

Shiao Li Oei, Anja Thronicke, Gerrit Grieb, Friedemann Schad, Jessica Groß

Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor models

Ryotaro Teranaka, Hiroshi Fujimoto, Takahito Masuda, Masayuki Kuroda, Yasuyuki Aoyagi, Takeshi Nagashima, Mamoru Takada, Junta Sakakibara, Hideyuki Yamada, Hiroto Yamamoto, Yoshitaka Kubota, Masayuki Ohtsuka

Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis

Huaying Dong, Changcheng Yang, Xiang Chen, Hening Sun, Xionghui He, Wei Wang

Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes

Fumiaki Sanuki, Yuka Mikami, Hirotake Nishimura, Yoshinori Fujita, Yasumasa Monobe, Tsunehisa Nomura, Naruto Taira, Takuya Moriya

Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer

Takeshi Murata, Masayuki Yoshida, Sho Shiino, Chikashi Watase, Ayumi Ogawa, Shohei Shikata, Hiromi Hashiguchi, Yukiko Yoshii, Hirokazu Sugino, Kenjiro Jimbo, Akiko Maeshima, Eriko Iwamoto, Shin Takayama, Akihiko Suto

Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting

Prashant Bhagwan Patil, Jayvadan Kantilal Patel

Glutaminase (GLS1) gene expression in primary breast cancer

Neelima Vidula, Christina Yau, Hope S. Rugo

Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer

Hiroki Kusama, Nobuyoshi Kittaka, Ai Soma, Azusa Taniguchi, Haruka Kanaoka, Satomi Nakajima, Yuri Oyama, Yukiko Seto, Jun Okuno, Noriyuki Watanabe, Saki Matsui, Minako Nishio, Fumie Fujisawa, Keiichiro Honma, Yasuhiro Tamaki, Takahiro Nakayama

Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer

Kazushi Suzuki, Rintaro Ohe, Takanobu Kabasawa, Takumi Kitaoka, Masaaki Kawai, Fuyuhiko Motoi, Mitsuru Futakuchi

Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?

Kadri Altundag

Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”

Shozo Ohsumi

Is there any association between acute kidney injury and olaparib use in patients with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

Kadri Altundag

Acknowledgments to reviewers 2023